Sign in

CIK 0001728328

  • Emerging growth company

Mentari Therapeutics, Inc.

Sign in to watch
Ticker
MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
981428279
Phone
+1 781-887-5080
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
InMed Pharmaceuticals Inc.
Open-market buys, last 90 days
$238,371
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$238K 10% owner 7 filings
Date Insider Transaction Shares Price Value Owned after
2023-12-23 HULL ANDREW Director Grant or award · Employee Stock Option (Right to Buy) +7,100 8,584
2023-12-05 WOUDENBERG MICHAEL Chief Operating Officer Other disposition · Employee Stock Option (Expiration) −848 10,494
2023-08-31 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Other disposition · Employee Stock Option (Expiration) −327 7,854
2023-05-16 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Other disposition · Employee Stock Option (Expiration) −152 8,181
2023-05-16 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Other disposition · Employee Stock Option (Expiration) −485 7,606
2023-05-16 ADAMS ERIC A President & CEO Other disposition · Employee Stock Option (Expiration) −1,818 26,139
2023-03-08 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Other disposition · Employee Stock Option (Expiration) −61 8,091
2023-03-08 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Other disposition · Employee Stock Option (Expiration) −545 8,333
2023-03-08 ADAMS ERIC A President & CEO Other disposition · Employee Stock Option (Expiration) −545 27,957
2022-12-16 Li Sarah VP Accounting & Controller Grant or award · Employee Stock Option (Right to Buy) +3,600 4,002
2022-12-16 Johnson Shane Aaron Sr VP & General Manager Grant or award · Employee Stock Option (Right to Buy) +4,200 8,000
2022-12-16 Lemerond Nicole Director Grant or award · Employee Stock Option (Right to Buy) +840 1,400
2022-12-16 WOUDENBERG MICHAEL Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +7,500 11,342
2022-12-16 Tegge Jonathan Interim CFO Grant or award · Employee Stock Option (Right to Buy) +1,400 1,400
2022-12-16 Grove Janet P Director Grant or award · Employee Stock Option (Right to Buy) +840 1,400
2022-12-16 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Grant or award · Employee Stock Option (Right to Buy) +4,200 8,878
2022-12-16 ADAMS ERIC A President & CEO Grant or award · Employee Stock Option (Right to Buy) +15,000 28,502
2022-12-16 Baldasare Bryan T Director Grant or award · Employee Stock Option (Right to Buy) +840 1,400
2022-12-16 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Grant or award · Employee Stock Option (Right to Buy) +4,200 8,152
2022-12-16 HULL ANDREW Director Grant or award · Employee Stock Option (Right to Buy) +840 1,484

Page 6 of 9 · 173 trades